Arnon Aharon
Chief Tech/Sci/R&D Officer bei CLAL BIOTECHNOLOGY INDUSTRIES LTD.
Profil
Arnon Aharon is the founder of ProMining Therapeutics Ltd.
which was founded in 2011.
Currently, he is the Medical Director at Clal Biotechnology Industries Ltd.
since 2022.
Dr. Aharon has previously worked as a Medical Director at LycoRed Ltd.
from 2009 to 2013 and at Thrombotech Ltd.
from 2009 to 2012.
He has also held positions as Director at Atox Bio Ltd., Chief Medical Officer at BioLineRx Ltd., Chief Clinical Research Officer at PainReform Ltd., Vice President-Development at Pharmos Ltd., and Partner at R&d Integrative Solutions.
From 2016 to 2021, he served as the Chief Medical Officer at Chemomab Therapeutics Ltd.
Dr. Aharon has an undergraduate and doctorate degree from Tel-Aviv University.
Aktive Positionen von Arnon Aharon
| Unternehmen | Position | Beginn |
|---|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Chief Tech/Sci/R&D Officer | 01.01.2022 |
Ehemalige bekannte Positionen von Arnon Aharon
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 03.12.2021 |
LycoRed Ltd.
 LycoRed Ltd. Pharmaceuticals: MajorHealth Technology Lycored Ltd. provides functional and nutritional ingredient solutions. It supplies natural carotenoids and other nutritional ingredients. The company was founded in 1985 and is headquartered in Beer Sheva, Israel. | Chief Tech/Sci/R&D Officer | 01.01.2013 |
Thrombotech Ltd.
 Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Chief Tech/Sci/R&D Officer | 01.01.2012 |
ProMining Therapeutics Ltd.
 ProMining Therapeutics Ltd. BiotechnologyHealth Technology ProMining Therapeutics Ltd. provides biopharmaceutical research and development services. It is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company was founded in 2011 and is headquartered in Nes Ziona, Israel. | Founder | - |
| BIOLINERX LTD. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Arnon Aharon
| Tel-Aviv University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| BIOLINERX LTD. | Health Technology |
| PAINREFORM LTD. | Health Technology |
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
LycoRed Ltd.
LycoRed Ltd. Pharmaceuticals: MajorHealth Technology Lycored Ltd. provides functional and nutritional ingredient solutions. It supplies natural carotenoids and other nutritional ingredients. The company was founded in 1985 and is headquartered in Beer Sheva, Israel. | Health Technology |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
| Pharmos Ltd. | |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
| R&d Integrative Solutions | |
ProMining Therapeutics Ltd.
ProMining Therapeutics Ltd. BiotechnologyHealth Technology ProMining Therapeutics Ltd. provides biopharmaceutical research and development services. It is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company was founded in 2011 and is headquartered in Nes Ziona, Israel. | Health Technology |
